Algeria's ANPP Joins US Pharmacopoeia as Voting Member

The Algerian National Agency for Pharmaceutical Products (ANPP) has announced its membership in the US Pharmacopoeia (USP) as a voting member. This development was revealed in a statement by the Ministry of Pharmaceutical Industry on November 9, 2026. The move is seen as a significant step for the ANPP to collaborate with international experts and institutions focused on improving pharmaceutical quality and safety.

The US Pharmacopoeia is a non-profit scientific organization that sets standards for the quality of medicines, dietary supplements, and chemical and biological raw materials. Its standards are globally recognized, and membership offers the ANPP an opportunity to engage with a broader international community. This affiliation also acknowledges Algeria's efforts in enhancing regulatory performance and protecting public health.

By joining the USP, the ANPP aims to contribute to the continuous improvement of pharmaceutical product quality in Algeria. This collaboration is expected to strengthen Algeria's position regionally and internationally, ensuring patient safety. The Ministry of Pharmaceutical Industry emphasized that this membership will facilitate the exchange of expertise and experiences with leading international institutions in the field.

The ANPP's membership in the USP is viewed as a strategic move to enhance the quality and safety of pharmaceutical products in Algeria. It reflects the country's commitment to adhering to international standards and best practices in the pharmaceutical sector. This development is anticipated to have a positive impact on the country's healthcare system.

The Ministry of Pharmaceutical Industry highlighted that the USP's standards are recognized worldwide, underscoring the significance of this partnership. The ANPP's involvement with the USP is expected to foster cooperation and knowledge sharing, ultimately benefiting the pharmaceutical industry in Algeria and the broader region.

Algeria's participation in the USP is seen as a step towards harmonizing national pharmaceutical standards with international norms. This alignment is crucial for ensuring the quality and safety of medicines available in the country. The ANPP's membership is also expected to enhance regulatory capacities, contributing to a more robust pharmaceutical sector.

The collaboration between the ANPP and the USP is poised to yield long-term benefits for Algeria's healthcare sector. By engaging with global experts and institutions, the ANPP can stay abreast of the latest developments and advancements in pharmaceutical quality and safety. This partnership underscores Algeria's commitment to prioritizing public health and safety in its pharmaceutical policies.

Key points

• ANPP joins US Pharmacopoeia as a voting member to enhance pharmaceutical quality and safety in Algeria.